As predicted, Prof Miles Prince is on track with getting underway in regard to the Clinical Sites for the PTX100 Phase 2a study. l am also very excited about the new CMO Dr Marissa Lim she has a wealth of experience and it is impeccable timing for her to be on board, it appears that James Mc Donnell and the board are forming a strong team to move forward. Also l am pleased that Epworth Freemasons are handling the first Clinical Trial as their Haematology Unit is one of the best in Australia, and l am keen to see the results from the USA and Europe's Clinicals Study. l hope many lives are saved by this amazing treatment and secondly l hope that genuine shareholders are rewarded in time.
PTX Price at posting:
4.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
